Literature DB >> 1878252

Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C.

M C Williams1, S Hawgood, R L Hamilton.   

Abstract

Pulmonary surfactant phospholipids may assume several different structures including tubular myelin, unilamellar and multilamellar vesicles, and others. These populations of materials appear to have similar phospholipid compositions but may differ in their association with surfactant proteins SP-A, SP-B, or SP-C. We have used electron microscopy to determine the changes in structure of simple lipid mixtures (phosphatidylglycerol, dipalmitoylphosphatidylcholine) produced by adding one or combinations of the three proteins. Adding SP-A to lipids generated multilamellar structures composed of membranes with fuzzy or particulate surfaces. In contrast, SP-B or SP-C generated discoidal particles and structures that appeared to be sheets of membrane formed by associated particles. Used together, SP-A and SP-B reorganized some of the lipid into tubular myelin, a structure that was not observed in SP-A, SP-C recombinants. These observations confirm the in vitro formation of tubular myelin reported by others and support the possibility that surfactant materials with defined structure can be produced in vitro for analyses of their molecular organizations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878252     DOI: 10.1165/ajrcmb/5.1.41

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  46 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Differential effects of surfactant protein A on regional organization of phospholipid monolayers containing surfactant protein B or C.

Authors:  S G Taneva; K M Keough
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.

Authors:  Guirong Wang; Svetla Taneva; Kevin M W Keough; Joanna Floros
Journal:  Biochim Biophys Acta       Date:  2007-07-06

Review 4.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 5.  Toxic oxidant species and their impact on the pulmonary surfactant system.

Authors:  E Putman; L M van Golde; H P Haagsman
Journal:  Lung       Date:  1997       Impact factor: 2.584

6.  Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids.

Authors:  S Taneva; K M Keough
Journal:  Biophys J       Date:  1994-04       Impact factor: 4.033

7.  Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice.

Authors:  J C Clark; S E Wert; C J Bachurski; M T Stahlman; B R Stripp; T E Weaver; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Immunogold localization of SP-A in lungs of infants dying from respiratory distress syndrome.

Authors:  D E deMello; S Heyman; D S Phelps; J Floros
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 9.  Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Gene       Date:  2012-10-12       Impact factor: 3.688

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.